Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes

被引:176
作者
Back, SA
Luo, NL
Mallinson, RA
O'Malley, JP
Wallen, LD
Frei, B
Morrow, JD
Petito, CK
Roberts, CT
Murdoch, GH
Montine, TJ
机构
[1] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA
[3] Oregon State Univ, Linus Paul Inst, Corvallis, OR 97331 USA
[4] Vanderbilt Univ, Dept Med, Nashville, TN USA
[5] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA
[6] Univ Miami, Dept Pathol, Miami, FL 33152 USA
[7] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97239 USA
[8] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
关键词
D O I
10.1002/ana.20530
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Periventricular white matter injury (PWMI) is the leading cause of cerebral palsy and chronic neurological disability in survivors of prematurity. Despite the large number of affected children, the pathogenetic mechanisms related to PWMI remain controversial. Through studies of 33 human autopsy brains, we determined that early PWMI was related to oxidative damage that particularly targeted the oligodendrocyte lineage, whereas other neuronal and glial cell types were markedly more resistant. F-2-isoprostanes, an arachidinate metabolite/lipid peroxidation marker of oxidative damage, were significantly increased in early PWMI lesions but not in cerebral cortex. That deleterious lipid peroxidation accompanied early PWMI was supported by similar increases in F-2-isoprostanes levels in the cerebral cortex from term infants with hypoxic-ischemic cortical injury. Detection of F-4-neuroprostanes, a neuronal-specific oxidative damage marker, confirmed that neuroaxonal elements were resistant to injury in cerebral cortex and white matter. Significant protein nitration was not detected in PWMI lesions by 3-nitrotyrosine staining. Significant cellular degeneration was confirmed in early PWMI lesions by terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling and a marked depletion of oligodendrocyte progenitors of 71 +/- 8%. Hence, the predilection of preterm infants for PWMI is related to selective lipid peroxidation-mediated injury of cerebral white matter and targeted death of oligodendrocyte progenitors.
引用
收藏
页码:108 / 120
页数:13
相关论文
共 70 条
[21]  
Dammann O, 1998, Semin Pediatr Neurol, V5, P190, DOI 10.1016/S1071-9091(98)80034-X
[22]   PATHOGENESIS AND EVOLUTION OF PERIVENTRICULAR LEUKOMALACIA IN INFANCY [J].
DEREUCK, J ;
CHATTHA, AS ;
RICHARDSON, EP .
ARCHIVES OF NEUROLOGY, 1972, 27 (03) :229-+
[23]   Identification of necrotic cell death by the TUNEL assay in the hypoxic-ischemic neonatal rat brain [J].
deTorres, C ;
Munell, F ;
Ferrer, I ;
Reventos, J ;
Macaya, A .
NEUROSCIENCE LETTERS, 1997, 230 (01) :1-4
[24]   Targeting human 8-oxoguanine glycosylase to mitochondria of oligodendrocytes protects against menadione-induced oxidative stress [J].
Druzhyna, NM ;
Hollensworth, SB ;
Kelley, MR ;
Wilson, GL ;
Ledoux, SP .
GLIA, 2003, 42 (04) :370-378
[25]   Rapid ischemic cell death in immature oligodendrocytes:: A fatal glutamate release feedback loop [J].
Fern, R ;
Möller, T .
JOURNAL OF NEUROSCIENCE, 2000, 20 (01) :34-42
[26]   Medical progress - Neonatal brain injury [J].
Ferriero, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (19) :1985-1995
[27]   Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter [J].
Folkerth, RD ;
Haynes, RL ;
Borenstein, NS ;
Belliveau, RA ;
Trachtenberg, F ;
Rosenberg, PA ;
Volpe, JJ ;
Kinney, HC .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (09) :990-999
[28]   Developmental differences in H2O2-induced oligodendrocyte cell death:: role of glutathione, mitogen-activated protein kinases and caspase 3 [J].
Fragoso, G ;
Martínez-Bermúdez, AK ;
Liu, HN ;
Khorchid, A ;
Chemtob, S ;
Mushynski, WE ;
Almazan, G .
JOURNAL OF NEUROCHEMISTRY, 2004, 90 (02) :392-404
[29]  
GOLD R, 1994, LAB INVEST, V71, P219
[30]   Microglia as mediators of inflammatory and degenerative diseases [J].
González-Scarano, F ;
Baltuch, G .
ANNUAL REVIEW OF NEUROSCIENCE, 1999, 22 :219-240